Neoplasia/BPH

	Cytoreductive cystectomy combined with chemotherapy versus chemotherapy alone in the treatment of metastatic bladder cancer: A retrospective comparative study. Cent European J Urol Hrechko BO, Voylenko O, Vitruk I, Stakhovsky O, Kononenko O, Pishak V, Stakhovsky E. PMID: 42904242 [PubMed]
	Prostate tissue microbiota dysbiosis associated with prostate cancer: results from the MICROPROSTK multicenter study. New Microbes New Infect Lotte R, Gaudart A, Cruzel C, Droupy S, Lavigne JP, Bruyère F, Lanotte P, Lechevallier E, Dubourg G, Fournier PE, Haider R, Lotte L, Youssef K, Emery A, Madany R, Payen M, Pfauwadel L, Tibi B, Ahallal Y, Zouari S, Bentellis I, Fontas E, Durand M, Ruimy R. PMID: 42904090 [PubMed]
	Reprogramming innate immune memory in bladder cancer: the proposed bone marrow-bladder axis and next-generation BCG-based immunotherapies. Front Immunol Yang M, Guo Y, Shen YZ, Sun YL, Ma DJ, Tang YJ. PMID: 42903705 [PubMed - indexed for MEDLINE]
	Results of radical prostatectomy and short-term follow-up of men with ISUP GG 1 and 2 prostate cancer who underwent magnetic resonance imaging-guided active surveillance. Cent European J Urol Busshoff I, Al-Monajjed R, Schimmöller L, Arsov C, Valentin B, Lakes J, Ullrich T, Hadaschik BA, Giganti F, Giessing M, Rau TT, Esposito I, Antoch G, Albers P, Boschheidgen M, Radtke JP. PMID: 42903620 [PubMed]
	Correction: Cardiovascular-kidney-metabolic health, genetic susceptibility, and incident cancer risk: a prospective UK biobank cohort and machine learning study. Front Endocrinol (Lausanne) He X, An J, Yan C, Zhou Y, Wu Z, Xu M, He Q. PMID: 42903428 [PubMed - in process]
	Integrating Mendelian randomization with single-cell and spatial transcriptomics to investigate gut microbiota-associated genetic signals and molecular characteristics in prostate cancer. Front Cell Infect Microbiol Qiu C, Zhang H, Du Z, Gao Y, Dai L. PMID: 42903126 [PubMed - indexed for MEDLINE]
	Prognostic value of postoperative dynamic PNI trajectories for biochemical recurrence in patients with high-risk localized prostate cancer: a longitudinal trajectory clustering study. Front Nutr Yu B, Dai X, Zhu J. PMID: 42903118 [PubMed]
	From Divergent Guidelines to Delphi-Ready Items: Tutorial for Large Language Model-Assisted Guideline Harmonization Using Penile Cancer as a Worked Example. J Med Internet Res Haas M, Rinderknecht E, May M, Burger M, Gilfrich C, Herrmann A, Brookman-May S, Eckl CA, Kruschwitz U, Ateia S, Donabauer G. PMID: 42902842 [PubMed - indexed for MEDLINE]
	Preoperative apical margin risk estimation from T2-weighted MRI radiomics in prostate cancer with MRI-visible apical tumors: toward multidisciplinary decision support. Asian J Androl Liu Y, Zhao YZ, Liu S, Gao XS, Ma MW. PMID: 42902531 [PubMed - as supplied by publisher]
	The clinical significance of the modified Naples prognostic score for prostate cancer: a population-based study. J Health Popul Nutr Zeng H, Yang F, Wang Q, Zhang T, Chen J, Jin S, Feng T, Liang Z, Chen Y, Xie Z, Tang C, Zhou Z, Zhou Y, Yan W. PMID: 42902334 [PubMed - indexed for MEDLINE]
	Lineage plasticity-driven immunometabolic state transitions in advanced prostate cancer: biomarkers and therapeutic stratification. Semin Immunopathol Wu H, Zhang W, Yan X, Ma K, Colucci M, Dong Q, Song P. PMID: 42902014 [PubMed - indexed for MEDLINE]
	MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer? Prostate Cancer Prostatic Dis Girometti R, Giannarini G, Crestani A, Urso L. PMID: 42901957 [PubMed - as supplied by publisher]
	Recovering anaerobic bacterial genomes in saliva, tumour and blood whole genome sequencing data from patients with prostate cancer. NPJ Biofilms Microbiomes Gihawi A, Bampalis A, Subramanian S, Pan Prostate Cancer Group, Bova GS, Butler A, Corcoran NM, Favero F, Gnanapragasam V, Hamid A, Jung C, Kote Jarai Z, Leeman G, Loda M, Reimand J, Sahli A, Schlomm T, Yamaguchi TN, Weischenfelft J, Hovens C, Pope B, Bristow R, Brook MN, Cheng KCL, Girma EG, Gruber AJ, He HH, Imada EL, Jakobsdottir GM, Khani F, Lutsik P, Marchionni L, Molania R, Papenfuss AT, Pellegrina D, Queiroz LR, Rausch T, Robinson B, Zanettini C, Sørensen KD, Lamy P, Cancel-Tassin G, Cussenot O, Eeles RA, Annels N, Hayes VM, Hurst R, Cooper CS, Brewer DS. PMID: 42901952 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol Patel SR, Rauf M, Geng Y, Hinojosa-Gonzalez D, Black JB, Lee T, Myers AA, Guo C, Li R, Meeks JJ, Agarwal P, Williams S, Alhalabi O, Necchi A, Mertens LS, Gontero P, Navai N, Kamat AM. PMID: 42901828 [PubMed - as supplied by publisher]
	Adjuvant therapy for renal cell carcinoma An update to the Canadian Kidney Cancer Forum consensus statement. Can Urol Assoc J Lalani AA, Lavallée LT. PMID: 42900894 [PubMed]
	Development and External Validation of a Machine Learning-Derived Risk Stratification Score for Metastatic Castration-Resistant Prostate Cancer. JCO Clin Cancer Inform Castro-Labrador L, Zamora R, Szyldergemajn S, Gómez Del Campo P, Del Castillo Izquierdo J, De All JA, Domínguez JM, Galmarini CM. PMID: 42900858 [PubMed - indexed for MEDLINE]
	Subsequent Detection of Clinically Significant Prostate Cancer After Suspicious MRI and an Initial Biopsy Negative for csPCa: A Longitudinal Subgroup Analysis of the MULTIPROS Trial. Prostate Aloufi WD, Szewczyk-Bieda M, Nabi G, Zhang X, Zhang Y, Wei C, Manfredi L. PMID: 42900782 [PubMed - as supplied by publisher]
	Spatial modulation enhances the effects of radiation on prostate cancer cells: a targeted mass spectrometry metabolomics study. Int J Radiat Biol Chen B, Rogers LJ, Liu K, Chen S, Deda R, Gotsbacher MP, Yang J, McKenzie DR, Suchowerska N, Kwan AH. PMID: 42900628 [PubMed - as supplied by publisher]
	Androgen Synthesis Inhibitors vs Androgen Receptor Inhibitors and Survival in Metastatic Hormone-Sensitive Prostate Cancer. JAMA Netw Open Gebrael G, Jo Y, Nandakumar V, Ozay ZI, Mercinelli C, Hooper G, Ostrowski M, Sayegh N, Lin E, Goel K, Li H, Thomas VM, Gupta S, Guha A, Riaz IB, Agarwal N, Swami U. PMID: 42900475 [PubMed - indexed for MEDLINE]
	Skin Toxic Effects and Survival With Enfortumab Vedotin-Pembrolizumab in Advanced Urothelial Carcinoma. JAMA Netw Open Thomas Z, Jiang CY, Speck PJ, Crupi E, Moussa MJ, Joseph A, Stender C, Glover M, Johns AC, Gao J, Desai M, Shah AY, Goswami S, Siefker-Radtke A, Karedath AR, Varughese SP, Ren W, Hassanzadeh C, Bree KK, Kamat AM, Guo CC, Pacha O, Patel A, Curry J, Sherry AD, Msaouel P, Campbell MT, Alhalabi O. PMID: 42900474 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192185

Page 1 of 9610



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy